INNERVATE RADIOPHARMACEUTICALS

Live / Registered — Registered (as of 24 Mar 2026)

What this means for you

Registered since 24 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
99064464
Registration number
8183382
Mark type
Stylized text
Filed
03 Mar 2025
Published for opposition
03 Feb 2026
Registered
24 Mar 2026
Attorney of record
Daniel P. Mullarkey

Goods and services

  • Class 042 — Scientific and technological services: Scientific research; Scientific research in the field of pharmacy; Research on the subject of pharmaceuticals; Medical research; Research and development services of new pharmaceutical products; Providing scientific information in the field of biochemistry, biotechnology and clinical trials; Scientific research consulting in the field of biotechnology, pharmaceutical research and development, and genetic science in relation to radiopharmaceuticals and cancer

Owner

Prosecution history

  • 24 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 24 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
  • 03 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 03 Feb 2026 — PUBLISHED FOR OPPOSITION
  • 28 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 07 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 06 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 06 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 06 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 03 Nov 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
  • 03 Nov 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
  • 05 Aug 2025 — NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
  • 05 Aug 2025 — EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
  • 05 Aug 2025 — COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
  • 05 Aug 2025 — EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

View this trademark record on Marksy